This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.

Identification and management of adverse reactions with cabozantinib in patients with advanced renal cell carcinoma

Renal Cell Carcinoma File
17 pages

A guide for healthcare professionals

CBZ-UK-000342 | November 2024

Identification and management of adverse reactions with cabozantinib in patients with advanced renal cell carcinoma
Explore more Renal Cell Carcinoma Resources

Explore more Renal Cell Carcinoma Resources

Browse